Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-05-08 | Dr. Burger received his M.Sc. and Ph.D. in Microbiology and Immunology from the University of Arizona. |
| 2020-04-24 | Dr. Burger received his M.Sc. and Ph.D. in Microbiology and Immunology from the University of Arizona. |
| 2021-04-21 | Dr. Burger received his M.Sc. and Ph.D. in Microbiology and Immunology from the University of Arizona. |
| 2022-04-20 | Dr. Burger received his M.Sc. and Ph.D. in Microbiology and Immunology from the University of Arizona. |
| 2023-04-19 | Dr. Burger makes valuable contributions to the Board based on his Ph.D. in microbiology and immunology, and his more than 25 years of experience in the biotechnology industry as a senior executive and as a corporate director. |
| 2024-05-15 | Dr. Burger received his M.Sc. and Ph.D. in Microbiology and Immunology from the University of Arizona. |
| 2024-07-17 | The table below sets forth information known to us regarding the beneficial ownership of our Shares as of July 11, 2024 for: each of our directors; ... Dr. Denis Burger: 34,427 shares. |
| 2024-12-30 | Name of Beneficial Owner: Dr. Denis Burger |
Data sourced from SEC filings. Last updated: 2025-10-11